Glimepiride (GM) is third generation sulfonylurea group and preferably used for the treatment of type -II diabetes mellitus. It belongs to BCS class II drugs according to biopharmaceutical classification system which shows low aqueous solubility. The purpose of this work was to develop and optimize glimepiride loaded chitosan- tripolyphosphate nanoparticles by ionotropic gelation method using 32 full factorial experimental designs. The developed chitosan nanoparticles were evaluated for particle size, zeta potential, entrapment efficiency, %yield and in vitro drug release etc. Factorial experimental design was implemented to optimize the independent variables like drug: polymer ratio (X1) and concentration of cross linking agent (X2) on dependent variables like particle size (Y1) and entrapment efficiency (Y2). A statistical analysis was performed using minitab 16 software with respect to ANOVA, regression analysis. The surface plots and contour plots represent the relationship between the experimental responses and the set of independent variables. The factorial experimental design was validated by checkpoint analysis and desirability function approach was applied for optimization of chitosan nanoparticle formulation. Drug entrapment efficiency and mean particle size of optimized formulation was found to be 61.25% and 222 nm respectively. Nanoparticles revealed initial burst release followed by slow drug release.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.